Mark Warner warns of military risks from BGI and DNA.

Senator Mark Warner suggested that BGI could surpass Huawei in scale and influence, as DNA data becomes a strategic asset linked to national security. He called for greater attention to biotechnology, viewing it as a key battleground in technological competition alongside telecommunications, AI, and semiconductors.

Overview

Speaking at the CNBC CFO Council Summit in Washington D.C., Mark Warner said, "If Huawei is big, BGI will be even bigger." According to him, BGI isn't building 5G infrastructure but is focused on collecting and processing DNA – a type of data that can be transformed into a strategic advantage when combined with AI.

BGI's capabilities and scope of operations

According to the National Security Committee on Emerging Biotechnology, BGI is one of the world's largest gene research companies, operating DNA sequencing laboratories in China and overseas. BGI processes genetic data for hospitals, pharmaceutical companies, and researchers in dozens of countries.

Starting as the Beijing Institute of Genomics, BGI is associated with national genome projects and has since expanded globally, selling services such as DNA sequencing, prenatal testing, cancer screening, and large-scale population genetic analysis, according to NBC News. BGI states that through its subsidiaries, it operates in the U.S., Europe, and Japan; in some countries, it has supported the development of national genetic databases and testing systems during the pandemic.

DNA data as a strategic asset

According to The Washington Post, on a large scale, genetic data is becoming a strategic asset leading to a “DNA arms race.” DNA profiles can reveal ancestry, physical traits, disease risk, and family relationships; when combined with AI, this data can support long-term biological surveillance, tracking, and research related to national security.

Links to the military and military risks

The House Special Committee on China warned BGI about its close ties to the Chinese government and military, amid concerns that China makes little distinction between commercial data and national security needs. A 2020 Wall Street Journal editorial by CIA Director John Ratcliffe, written during his first term as Director of National Intelligence under President Trump, highlighted Chinese research including population DNA collection, military databases, and AI-based human performance modeling.

Mark Warner directly addressed concerns about the potential for “human performance enhancement” and military biotechnology: “It’s terrifying.”

Model comparison: BGI and Huawei

Mark Warner sees a familiar trajectory: Huawei has previously leveraged state support, competitive pricing, and access to global markets to infiltrate telecommunications infrastructure before governments fully assessed the security implications. The U.S. blacklisted Huawei in 2019; by then, he said, “we had already started to lose a little bit” as much of the 5G infrastructure was already shaped by Chinese technology. He predicts BGI could do the same in biotechnology.

Policies and feedback

According to the Foundation of Defense of Democracies, BGI's access to US organizations needs to be restricted. The US Congress has pushed through versions of the BIOSECURE Act aimed at limiting the operations of Chinese biotechnology companies in the US. Several hospitals and research organizations in the US are under federal pressure; many medical professionals fear losing crucial research support.

BGI responded: “The BIOSECURE Act is a false flag targeting companies under the pretext of national security. We strictly adhere to the law and do not access the personal data of Americans in any way.”

Intelligence capabilities and alliance coordination

Mark Warner argues that U.S. intelligence has been slow to respond to the threat of biotechnology, due to a greater focus on foreign governments and militaries than on commercial technology. He says the U.S. has only seriously expanded its intelligence gathering on AI, semiconductors, and biotechnology in the last two to three years. For example, SMIC's creation of 6nm chips "stunned U.S. officials," demonstrating an underestimation of technical capabilities and limited countermeasures.

He emphasized the need for closer alliance cooperation, given that relationships – including the Five Eyes network – had weakened; some partners, such as the United Kingdom, the Netherlands, and France, were reluctant to share information for fear of "politicizing" intelligence products.

The battle over technology standards

According to Mark Warner, the U.S. is ceding its leading role in setting international standards – a "secret" that has helped the U.S. lead economically and technologically for decades. China is reportedly increasing its personnel presence at standards bodies, "nearly dominating the votes." Stronger re-engagement is necessary to protect U.S. business and government interests, and to set ethical boundaries in areas such as biotechnology.

Military-Technical Perspective

• The technical focus: collecting, sequencing, and analyzing DNA data on a large scale, combining AI to model human biological characteristics.
• Operational implications: Genetic databases can support biological surveillance, tracking, and research for national security; risks increase if there is a lack of distinction between commercial and military data.
• Response measures: enhance technological intelligence gathering; tighten regulations on access to sensitive data; coordinate with allies and participate in establishing international standards.

In conclusion, according to Mark Warner, BGI represents a new generation of challenges where biometric data becomes a strategic leverage. The lesson from Huawei shows the need for early, coordinated action in intelligence, policy, and standards.

CTVX